Hepatitis C Market Forecast

Product Code DAT14424
Publication Date January 2009
Publisher Datamonitor
Product Type Interactive Model
Pages 0
ISBN Number not applicable
Change currency
PDF £8,365.00 €10,073 $13,227 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Hepatitis C Market Forecast

Introduction
The Hepatitis C market was worth $2.3 billion in 2007, declining at a CAGR of -2.8% from 2004-2007. Despite this recent slump, Datamonitor forecasts sales to grow to $4.5 billion by 2017, driven primarily by the launch of the new protease inhibitors. The US and EU will remain the largest markets, generating $1.9 billion and $1.7 billion respectively in 2017.

Scope



Highlights



Reasons to Purchase


  • Understand current and future Hepatitis C market dynamics
  • Gain insight into the unmet needs of HCV patients and the extent to which pipeline drugs are addressing these issues
  • Assess current and future market size and the impact of new drug launches

    • Contents

    • Please note that this product is delivered as an interactive model. The model is an Excel document and its data can be manipulated and used as per your needs. The data when extracted and used must be correctly cited to the publisher. This product does not include numbers of pages due to the format that it is supplied in. Should you have any queries regarding the model or would like a demo please do not hesitate to call us on Tel: +44 (0) 20 7060 7474 or email our customer service on service@reportbuyer.com